πŸ‡ΊπŸ‡Έ FDA
Patent

US 11390600

Crystalline forms of C21H22Cl2N4O2

granted A61KA61K31/4439A61K45/06

Quick answer

US patent 11390600 (Crystalline forms of C21H22Cl2N4O2) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4439, A61K45/06, A61P, A61P35/00